For most of human history, light was understood as something the body responds to — it sets the circadian clock, drives vitamin D synthesis, and signals the nervous system to shift between alert and restful states. This understanding, while accurate, is incomplete.
At the cellular level, specific wavelengths of light are not merely detected — they are absorbed, converted, and used as a direct input to mitochondrial energy production. This is the mechanism behind photobiomodulation (PBM), one of the most extensively studied non-pharmacological interventions in contemporary biomedical research.
The Mitochondrial Mechanism
Cytochrome c oxidase (CCO) is the terminal enzyme of the mitochondrial electron transport chain — the molecular machine responsible for the final step in converting oxygen and electrons into the electrochemical gradient that drives ATP synthesis. CCO contains copper and haem centres that absorb photons at specific wavelengths: 660 nm (red) and 850 nm (near-infrared).
When these wavelengths are delivered at appropriate irradiance levels, CCO activity increases. The enzyme's affinity for its substrate improves, electron transport accelerates, and ATP output rises. Simultaneously, the production of reactive oxygen species decreases, and nitric oxide — which normally competes with oxygen at the active site — is displaced, allowing the chain to run more efficiently.
Downstream Effects
The downstream consequences of improved CCO function extend far beyond energy yield. ATP is the currency of virtually every cellular process — protein synthesis, membrane repair, ion pump activity, and immune signalling all depend on it. Cells with adequate ATP are better positioned to repair damage, resist stress, and perform their specialised functions.
Nitric oxide, released from the enzyme complex when displaced by photons, acts as a vasodilator in surrounding tissue, improving local circulation. Reduced oxidative stress lowers the inflammatory signal, which in turn reduces the chronic, low-grade activation of the immune system that characterises many age-related conditions.
Wavelength Specificity Matters
Not all light produces these effects. The photobiomodulation response is highly wavelength-dependent — the biological window for effective PBM lies between approximately 600 and 1100 nm, with the strongest evidence concentrated at 660 nm and 850 nm. Visible light below this range lacks sufficient penetration depth; wavelengths above 1100 nm are absorbed primarily by water before reaching target tissues.
Irradiance — the power delivered per unit area — also determines outcome. Too little and the biological threshold is not crossed; too much activates stress responses that counteract the benefit. Effective PBM delivery requires precision: the right wavelengths, at the right dose, for the right duration.
Light Within the Regen Pod
Inside the Regen Pod, photobiomodulation is one of five concurrent energy modalities. Red and near-infrared light are delivered at clinically validated wavelengths and irradiance levels across the full body surface area — a delivery method that addresses systemic mitochondrial function rather than a single anatomical site.
The integration of PBM with PEMF, far-infrared, acoustic resonance and mechanical vibration creates a biological environment in which multiple repair and optimisation pathways are activated simultaneously. The Regen PhD model does not treat these modalities as interchangeable — each has a defined mechanism, and the session is engineered around their combined effect. Light is not an accessory here. It is foundational.